Dr. Mansukh Mandaviya interacts with representatives of Japanese Pharma Companies

The Union Health Minister said that the Indian pharmaceutical industry has primarily focused on manufacturing generic medicines, exporting bulk drugs, and supplying active pharmaceutical ingredients.

Related Keywords

Tokyo ,Japan ,India ,Japanese ,Daikichiro Kobayashi ,Hiroyoshi Tosa ,Junichi Shiraishi ,Osamu Okuda ,Sunao Manabe ,Mansukh Mandaviya ,Shri Vishal Chauhan ,Sachiko Nakagawa ,Japanese Pharma Companies ,Union Health ,Health Ministry ,Indian Embassy ,Japan Pharmaceutical Manufacturers Association ,Institute Of National Importance ,National Institutes Of Pharmaceutical Education ,Chugai Pharmaceutical Co Ltd ,Meiji Seika Pharma Co Ltd ,Otsuka Chemical Co Ltd ,Daiichi Sankyo Co Ltd ,Union Minister ,Family Welfare ,Director General ,Managing Director ,Union Health Minister ,Drug Parks ,National Institutes ,Pharmaceutical Education ,New Drugs ,Clinical Trial Rules ,Production Link Incentive ,Compound Annual Growth Rate ,Vishal Chauhan ,Joint Secretary ,Representative Director ,Executive Chairperson ,With Inputs ,